Notice of Change in Key Dates for PAR-16-176 "NCI Clinical and Translational Exploratory/Developmental Studies (R21)"

Notice Number: NOT-CA-16-065

Key Dates
Release Date: September 2, 2016

Related Announcements
NOT-CA-16-037
PAR-16-176

Issued by
National Cancer Institute (NCI)

Purpose

This Notice modifies the Key Dates Section of Funding Opportunity PAR-16-176 "NCI Clinical and Translational Exploratory/Developmental Studies (R21)" by adjusting the Application Due Date(s), and the AIDS Application Due Date(s)..

Part 1. Key Dates

Currently reads:

Application Due Date(s): July 19, 2016; November 22, 2016; March 22, 2017; July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s): July 19, 2016; November 22, 2016; March 22, 2017; July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization.

Modified to read:

Application Due Date(s): July 19, 2016; October 18, 2016; February 21, 2017; June 19, 2017; October 17, 2017; February 20, 2018; June 19, 2018; October 17, 2018; February 20, 2019, by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s): July 19, 2016; November 22, 2016; March 22, 2017; July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2019, by 5:00 PM local time of applicant organization.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

William C. Timmer, Ph.D
National Cancer Institute (NCI)
Telephone: 240-276-6130
Email: [email protected]